Autopsy report · NCT02522676

Evaluation of Different Treatment Modalities for Lower Pole and Renal Pelvis Stones

“Due to surgeons' unwillingness to randomize patients into different treatments”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 10 months before it started.
• Suspended: paused, and may or may not restart.
• 300 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Selcuk University

Sponsor type

University, hospital or other

Conditions

Kidney Stones

Interventions

Endoscopic kidney stone surgery; Endoscopic kidney stone surgery; Endoscopic kidney stone surgery; Endoscopic kidney stone surgery; Endoscopic kidney stone surgery; Non-invasive kidney stone treatment

Participants

300 (planned, not actual)

Sites

1

Countries

Turkey (Türkiye)

Trials that died the same way

• Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
  “No patients randomised” (62% match in meaning)
• Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas
  “Was not able to recruit patients for randomization.” (61% match in meaning)
• Quadrant Versus Superficial Parotidectomy
  “Lack of enrollment of eligible patients for randomization.” (60% match in meaning)
• Optimization Lumbar Puncture In Children
  “Due to the reason that not all participants agree to have anesthesia and postoperative management at the same time” (59% match in meaning)
• Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial
  “inability to recruit more patients” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.